The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review
International Journal of Environmental Research and Public Health · 07.02.2023 · 20 (4) · 2904
DOI: 10.3390/ijerph20042904 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Environmental Research and Public Health, online erschienen am 07.02.2023. Verfasst von Emil Saeed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Medical University of Bialystok, Kilinskiego 1 STR, 15-089 Bialystok, Poland. Hauptthemen laut MEDLINE: Glaucoma, Open-Angle, Glaucoma, Glaucoma Drainage Implants. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recently, the quest for novel glaucoma surgical techniques and devices has been underway. Trabeculectomy remains the gold standard, but it requires the implantation of glaucoma drainage devices and frequent follow-ups, and it also carries a high risk of serious complications. The need for less invasive and safer procedures has led to the development of minimally invasive glaucoma surgery (MIGS), particularly for patients with mild–to–moderate disease. Among them, minimally invasive bleb surgery seems to be effective in classical glaucoma surgery, while maintaining MIGS benefits. The relatively new PreserFlo® MicroShunt (Santen, Osaka, Japan) is registered in Europe. It was released in 2019 for the treatment of patients with early–to–advanced open-angle glaucoma, where intraocular pressure (IOP) remains uncontrolled while on maximum tolerated medication and/or where glaucoma progression warrants surgery. This review focuses on the place of the PreserFlo MicroShunt, characterized by ab externo implantation, among MIGS procedures, discussing its advantages and disadvantages. The mechanisms of action, technical aspects, efficacy, and safety issues are summarized. The surgical technique, its efficacy, and safety profile are described, and directions for future studies are indicated. The PreserFlo MicroShunt ensures a high safety profile, minimal anatomical disruption, meaningful IOP-lowering effect, and ease of use for patients and physicians.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Medical University of Bialystok, Kilinskiego 1 STR, 15-089 Bialystok, Poland.
ORCID-Profile: Diana Anna Dmuchowska, Joanna Konopińska
Zitieren
APA
Saeed, E., Gołaszewska, K., Dmuchowska, D. A., Zalewska, R., & Konopińska, J. (2023). The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review. International Journal of Environmental Research and Public Health, 20(4), 2904. https://doi.org/10.3390/ijerph20042904
Vancouver
Saeed E, Gołaszewska K, Dmuchowska DA, Zalewska R, Konopińska J. The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review. International Journal of Environmental Research and Public Health. 2023;20(4):2904. doi:10.3390/ijerph20042904
BibTeX
@article{Saeed2023,
author = {Saeed, Emil and Gołaszewska, Kinga and Dmuchowska, Diana Anna and Zalewska, Renata and Konopińska, Joanna},
title = {The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review},
journal = {International Journal of Environmental Research and Public Health},
year = {2023},
volume = {20},
number = {4},
pages = {2904},
doi = {10.3390/ijerph20042904}
}
EUVIMED